04:13 PM EDT, 08/05/2024 (MT Newswires) -- BioMarin Pharmaceutical ( BMRN ) reported Q2 non-GAAP earnings Monday of $0.96 per share, up from $0.54 a year earlier.

Analysts surveyed by Capital IQ expected $0.60.

Revenue for the quarter ended June 30 was $712 million, up from $595.3 million a year ago.

Analysts polled by Capital IQ expected $664 million.

The company raised its full-year non-GAAP earnings guidance to $3.10 to $3.25 per share on revenue of $2.75 billion to $2.83 billion.

The company's previous forecast was non-GAAP earnings of $2.75 to $2.95 per share on revenue of $2.70 billion to $2.80 billion.

Analysts surveyed by Capital IQ expect $2.87 on revenue of $2.74 billion.

Price: 84.50, Change: +4.03, Percent Change: +5.01